| Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients FC Barreto, DV Barreto, S Liabeuf, N Meert, G Glorieux, M Temmar, ... Clinical Journal of the American Society of Nephrology 4 (10), 1551-1558, 2009 | 944 | 2009 |
| Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease S Liabeuf, DV Barreto, FC Barreto, N Meert, G Glorieux, E Schepers, ... Nephrology Dialysis Transplantation 25 (4), 1183-1191, 2010 | 470 | 2010 |
| Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease Sharp Collaborative Group American heart journal 160 (5), 785-794. e10, 2010 | 411 | 2010 |
| Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease DV Barreto, FC Barreto, S Liabeuf, M Temmar, HD Lemke, C Tribouilloy, ... Kidney international 77 (6), 550-556, 2010 | 372 | 2010 |
| The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report LJ Schurgers, DV Barreto, FC Barreto, S Liabeuf, C Renard, ... Clinical journal of the American society of nephrology 5 (4), 568-575, 2010 | 363 | 2010 |
| FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages L Desjardins, S Liabeuf, C Renard, A Lenglet, HD Lemke, G Choukroun, ... Osteoporosis International 23, 2017-2025, 2012 | 275 | 2012 |
| Pulse wave velocity and vascular calcification at different stages of chronic kidney disease M Temmar, S Liabeuf, C Renard, S Czernichow, N El Esper, I Shahapuni, ... Journal of hypertension 28 (1), 163-169, 2010 | 231 | 2010 |
| Vitamin D affects survival independently of vascular calcification in chronic kidney disease DV Barreto, FC Barreto, S Liabeuf, M Temmar, F Boitte, G Choukroun, ... Clinical journal of the American Society of Nephrology 4 (6), 1128-1135, 2009 | 212 | 2009 |
| Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients S Liabeuf, A Lenglet, L Desjardins, N Neirynck, G Glorieux, HD Lemke, ... Kidney international 82 (12), 1297-1303, 2012 | 180 | 2012 |
| Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease E Schepers, DV Barreto, S Liabeuf, G Glorieux, S Eloot, FC Barreto, ... Clinical Journal of the American Society of Nephrology 6 (10), 2374-2383, 2011 | 171 | 2011 |
| Protein-bound uremic toxins: new insight from clinical studies S Liabeuf, TB Drüeke, ZA Massy Toxins 3 (7), 911-919, 2011 | 154 | 2011 |
| Anemia and iron deficiency among chronic kidney disease Stages 3–5ND patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: often unmeasured, variably treated MMY Wong, C Tu, Y Li, RL Perlman, R Pecoits-Filho, AA Lopes, I Narita, ... Clinical kidney journal 13 (4), 613-624, 2020 | 120 | 2020 |
| The drugs that mostly frequently induce acute kidney injury: a case− noncase study of a pharmacovigilance database M Pierson‐Marchandise, V Gras, J Moragny, J Micallef, L Gaboriau, ... British journal of clinical pharmacology 83 (6), 1341-1349, 2017 | 106 | 2017 |
| Estimated glomerular filtration rate is a poor predictor of concentration for a broad range of uremic toxins S Eloot, E Schepers, DV Barreto, FC Barreto, S Liabeuf, W Van Biesen, ... Clinical Journal of the American Society of Nephrology 6 (6), 1266-1273, 2011 | 97 | 2011 |
| Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario? S Liabeuf, H Okazaki, L Desjardins, D Fliser, D Goldsmith, A Covic, ... Nephrology Dialysis Transplantation 29 (7), 1275-1284, 2014 | 96 | 2014 |
| Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study A Lenglet, S Liabeuf, N El Esper, S Brisset, J Mansour, AS Lemaire-Hurtel, ... Nephrology Dialysis Transplantation 32 (5), 870-879, 2017 | 94 | 2017 |
| Uremic toxicity and sclerostin in chronic kidney disease patients L Desjardins, S Liabeuf, RB Oliveira, L Louvet, S Kamel, HD Lemke, ... Nephrologie & therapeutique 10 (6), 463-470, 2014 | 93 | 2014 |
| Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein S Liabeuf, B Olivier, C Vemeer, E Theuwissen, E Magdeleyns, CE Aubert, ... Cardiovascular diabetology 13, 1-8, 2014 | 91 | 2014 |
| Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein S Liabeuf, B Olivier, C Vemeer, E Theuwissen, E Magdeleyns, CE Aubert, ... Cardiovascular diabetology 13, 1-8, 2014 | 91 | 2014 |
| Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD‐REIN cohort SM Laville, M Metzger, B Stengel, C Jacquelinet, C Combe, D Fouque, ... British Journal of Clinical Pharmacology 84 (12), 2811-2823, 2018 | 80 | 2018 |
Choukroun GabrielProfesseur de Nephrologie, CHU Amiens et Université de Picardie Jules VerneVerified email at chu-amiens.fr
